Results 11 to 20 of about 299,239 (347)
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
Journal of Pure and Applied Microbiology, 2020 Rapidly spreading outbreak of the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is causing serious health concerns worldwide.
Hiren A. Dhameliya +4 more
doaj +3 more sources
COVID-19 Drug Treatment in China. [PDF]
Curr Pharmacol Rep, 2020 An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19.At present, the strategy of new use of old drugs is ...
Fan L, Jiang S, Yang X, Wang Z, Yang C.
europepmc +4 more sources
Drug repurposing in the treatment of COVID-19: A review [PDF]
Research in Pharmacy, 2021 The first outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was in Wuhan, Hubei, China in December 2019 and declared as a pandemic by the World Health Organization.
Madhuri, D. Game +2 more
core +4 more sources
Clinical trials on drug repositioning for COVID-19 treatment [PDF]
Revista Panamericana de Salud Pública, 2020 The World Health Organization (WHO) was informed on December 2019 about a coronavirus pneumonia outbreak in Wuhan, Hubei province (China). Subsequently, on March 12, 2020, 125,048 cases and 4,614 deaths were reported. Coronavirus is an enveloped RNA virus, from the genusBetacoronavirus, that is distributed in birds, humans, and other mammals.
Sandro G. Viveiros-Rosa +1 more
openalex +4 more sources
Drug Repurposing in the Treatment of COVID-19
Bezmialem Science, 2020 The use of drugs that have been previously defined for certain indications in new indications is defined as the repurposing/repositioning of the drug. The requirement of all clinical research steps that starts from healthy volunteers, due to the slowness of new drug discovery, longer time to reach the market, and high cost to develop a new drug, make ...
Mehmet Soylu +2 more
openalex +3 more sources
Drug Repositioning In The Treatment Of Covid-19
Journal of Medical Pharmaceutical And Allied Sciences, 2020 Ravella Sai Yamini
openalex +2 more sources
Old and new antirheumatic drugs for the treatment of COVID-19
Joint Bone Spine, 2020 Maurizio Benucci +4 more
openalex +4 more sources
Old and re-purposed drugs for the treatment of COVID-19 [PDF]
Expert Review of Anti-infective Therapy, 2020 Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It has caused a global pandemic with more than three hundred thousand case fatalities.
Shio-Shin Jean, Po‐Ren Hsueh
openalex +4 more sources
COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. [PDF]
British Journal of Clinical Pharmacology, 2020 In a recent issue of Br J Clin Pharmacol Smith et al1 published an outstanding commentary titled ‘Dosing will be a key success factor in repurposing antivirals for Covid-19’. They highlighted that the success in our repurposing efforts will be dependent on ‘getting the dose right’ for drugs which have been developed for different indications and ...
David Back +7 more
openalex +9 more sources
Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? [PDF]
Frontiers in Medicine, 2021 Coronavirus disease 2019 (COVID-19) is now at the forefront of major health challenge faced globally, creating an urgent need for safe and efficient therapeutic strategies. Given the high attrition rates, high costs, and quite slow development of drug discovery, repurposing of known FDA-approved molecules is increasingly becoming an attractive issue in
Christian A. Devaux +7 more
openaire +5 more sources